Passage Bio announces 1-for-20 reverse stock split effective July 14, 2025

Passage BIO, Inc.

Reverse split ratio 1-for-20; effective 12:01 a.m. ET on July 14, 2025.
Pre-split shares ~62.4M; post-split ~3.12M shares outstanding.
Action intended to regain Nasdaq minimum $1.00 bid price compliance.
No fractional shares; holders of fractional shares receive rounded-up whole share.
No change to authorized shares (125M), par value ($0.0001), or voting rights.

item 3.03item 5.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.